Stay updated on Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study expanded its locations to 44 sites across multiple countries, adding Busan (South Korea), Michalovce (Slovakia), Cebu (Philippines), San Luis Potosí City (Mexico), and Mexico City (Mexico). This broadens geographic participation and potential enrollment for the trial.
    Difference
    0.6%
    Check dated 2026-07-30T14:33:00.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, signaling a new version of the page. This update appears to reflect behind-the-scenes maintenance rather than changes to study details.
    Difference
    0.0%
    Check dated 2026-07-23T09:47:27.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.1 to v3.6.3, indicating a newer deployment of the page template.
    Difference
    0.0%
    Check dated 2026-07-02T02:52:00.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.6.1 replaces the previous v3.6.0 on the page. This indicates a small update to the page’s revision metadata rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-06-25T01:15:36.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page gains new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment note indicating recruitment is closed; the Intervention/Treatment header is standardized, and the revision note updates from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-10T19:45:17.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Study locations were updated to reflect a new Blacksburg, VA site (ZIP 24060) and the removal of the previous ZIP 24014. This change updates the geographic availability of trial sites.
    Difference
    0.2%
    Check dated 2026-06-03T09:37:32.000Z thumbnail image

Stay in the know with updates to Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial page.